DrugPatentWatch Database Preview
Details for Patent: 8,227,484
Which drugs does patent 8,227,484 protect, and when does it expire?
This patent has fifty-eight patent family members in twenty-one countries.
Summary for Patent: 8,227,484
Title: | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
Abstract: | Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine. |
Inventor(s): | Yakatan; Gerald (Del Mar, CA), Berg; James (San Diego, CA), Pope; Laura (Carlsbad, CA), Smith; Richard Alan (La Jolla, CA) |
Assignee: | Avanir Pharmaceuticals, Inc. (Aliso Viejo, CA) |
Application Number: | 13/415,067 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,227,484
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Avanir Pharms | NUEDEXTA | dextromethorphan hydrobromide; quinidine sulfate | CAPSULE;ORAL | 021879-001 | Oct 29, 2010 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | TREATMENT OF PSEUDOBULBAR AFFECT | ➤ Try a Free Trial | |||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 8,227,484
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
7,659,282 | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |
International Patents Family Members for US Patent 8,227,484
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Taiwan | 200403997 | ➤ Try a Free Trial | |||
Slovenia | 1980252 | ➤ Try a Free Trial | |||
Slovenia | 1539166 | ➤ Try a Free Trial | |||
Russian Federation | 2341265 | ➤ Try a Free Trial | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |